RecruitingNot ApplicableNCT07331753
The Outcomes of Fat Grafting Combined With Latissimus Dorsi Muscle Flap for Delayed Breast Reconstruction After Mastectomy
Sponsor
Sohag University
Enrollment
20 participants
Start Date
Nov 1, 2025
Study Type
INTERVENTIONAL
Conditions
Summary
The outcomes of fat grafting combined with latissimus dorsi muscle flap for delayed breast reconstruction after mastectomy
Eligibility
Sex: FEMALEMin Age: 18 Years
Plain Language Summary
Simplified for easier understanding
This study is looking at the outcomes of a breast reconstruction technique that combines fat grafting (using the patient's own fat) with a muscle flap from the back (latissimus dorsi) for women who had a mastectomy and are having delayed reconstruction.
**You may be eligible if...**
- You are a female patient who is scheduled for a skin-sparing mastectomy
- You are seeking delayed breast reconstruction after mastectomy
**You may NOT be eligible if...**
- You have stage 4 (metastatic) breast cancer
Talk to your doctor to see if this trial is right for you.
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
PROCEDUREFat grafting combined with latissimus dorsi muscle flap
Fat grafting combined with latissimus dorsi muscle flap for delayed breast reconstruction
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07331753
Related Trials
Genomic Services Research Program
NCT025959571 location
Safety and Tolerability of ²¹²Pb-DOTAM-GRPR1 in Adult Subjects With Recurrent or Metastatic GRPR-expressing Tumors
NCT052833304 locations
A Synthetic Lethality-Focused Algorithm to Identify Therapeutic Options in Advanced Metastatic Breast Cancer (SYNTHESIS-Breast)
NCT070671381 location
Social and Environmental Determinants of Breast Cancer Survivorship: the Black Breast Cancer Survivor's Intervention (BBCSI)
NCT068852031 location
A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer
NCT06103864316 locations